2-161974255-C-G

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting

The NM_001178015.2(SLC4A10):​c.3166C>G​(p.Gln1056Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000305 in 1,605,336 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.0015 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00018 ( 1 hom. )

Consequence

SLC4A10
NM_001178015.2 missense

Scores

1
3
15

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2B:1

Conservation

PhyloP100: 3.53

Publications

3 publications found
Variant links:
Genes affected
SLC4A10 (HGNC:13811): (solute carrier family 4 member 10) This gene belongs to a small family of sodium-coupled bicarbonate transporters (NCBTs) that regulate the intracellular pH of neurons, the secretion of bicarbonate ions across the choroid plexus, and the pH of the brain extracellular fluid. The protein encoded by this gene was initially identified as a sodium-driven chloride bicarbonate exchanger (NCBE) though there is now evidence that its sodium/bicarbonate cotransport activity is independent of any chloride ion countertransport under physiological conditions. This gene is now classified as a member A10 of the SLC4 family of transmembrane solute carriers. Alternative splicing results in multiple transcript variants encoding distinct isoforms.[provided by RefSeq, May 2010]
SLC4A10 Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder with hypotonia and characteristic brain abnormalities
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Baylor College of Medicine Research Center, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0072874725).
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00152 (232/152240) while in subpopulation AFR AF = 0.00505 (210/41562). AF 95% confidence interval is 0.00449. There are 0 homozygotes in GnomAd4. There are 111 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC4A10NM_001178015.2 linkc.3166C>G p.Gln1056Glu missense_variant Exon 24 of 27 ENST00000446997.6 NP_001171486.1 Q6U841-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC4A10ENST00000446997.6 linkc.3166C>G p.Gln1056Glu missense_variant Exon 24 of 27 1 NM_001178015.2 ENSP00000393066.1 Q6U841-1

Frequencies

GnomAD3 genomes
AF:
0.00153
AC:
232
AN:
152124
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00507
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000786
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00336
GnomAD2 exomes
AF:
0.000366
AC:
87
AN:
237660
AF XY:
0.000242
show subpopulations
Gnomad AFR exome
AF:
0.00427
Gnomad AMR exome
AF:
0.000573
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000372
Gnomad OTH exome
AF:
0.000171
GnomAD4 exome
AF:
0.000177
AC:
257
AN:
1453096
Hom.:
1
Cov.:
29
AF XY:
0.000159
AC XY:
115
AN XY:
721706
show subpopulations
African (AFR)
AF:
0.00483
AC:
161
AN:
33306
American (AMR)
AF:
0.000482
AC:
21
AN:
43552
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25880
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39520
South Asian (SAS)
AF:
0.0000238
AC:
2
AN:
83926
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53098
Middle Eastern (MID)
AF:
0.000869
AC:
5
AN:
5754
European-Non Finnish (NFE)
AF:
0.0000433
AC:
48
AN:
1107940
Other (OTH)
AF:
0.000333
AC:
20
AN:
60120
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.443
Heterozygous variant carriers
0
11
23
34
46
57
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00152
AC:
232
AN:
152240
Hom.:
0
Cov.:
32
AF XY:
0.00149
AC XY:
111
AN XY:
74436
show subpopulations
African (AFR)
AF:
0.00505
AC:
210
AN:
41562
American (AMR)
AF:
0.000785
AC:
12
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
67990
Other (OTH)
AF:
0.00332
AC:
7
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
11
23
34
46
57
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000145
Hom.:
0
Bravo
AF:
0.00168
ESP6500AA
AF:
0.00536
AC:
20
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000414
AC:
50
Asia WGS
AF:
0.00173
AC:
6
AN:
3476

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:1
Aug 11, 2016
Athena Diagnostics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Uncertain:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

SLC4A10-related disorder Benign:1
Apr 24, 2023
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.065
BayesDel_addAF
Benign
-0.32
T
BayesDel_noAF
Benign
-0.23
CADD
Benign
19
DANN
Benign
0.49
DEOGEN2
Benign
0.0021
.;.;T;T
Eigen
Benign
-0.44
Eigen_PC
Benign
-0.11
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.92
D;D;D;D
M_CAP
Benign
0.041
D
MetaRNN
Benign
0.0073
T;T;T;T
MetaSVM
Benign
-0.77
T
MutationAssessor
Benign
-0.14
.;.;.;N
PhyloP100
3.5
PrimateAI
Uncertain
0.73
T
PROVEAN
Benign
0.91
N;N;N;N
REVEL
Uncertain
0.37
Sift
Benign
1.0
T;T;T;T
Sift4G
Benign
1.0
T;T;T;T
Polyphen
0.0
.;B;.;B
Vest4
0.32
MVP
0.71
MPC
0.0093
ClinPred
0.021
T
GERP RS
5.2
Varity_R
0.16
gMVP
0.30
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142943771; hg19: chr2-162830765; API